MedTrace Logo

Mild Cognitive Impairment and Endurance Exercise in Parkinson's Disease

NCT03542474 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2020-07-14

Study results available
· View outcomes & findings →

Summary

The overall objective of this study is to determine how high intensity endurance exercise affects both cognition and the signs and symptoms of Parkinson's disease as well as if certain brain structures and functions also change with this exercise.

Conditions

Interventions

BEHAVIORAL

High Intensity Endurance Exercise

Treadmill exercise at 80%-85% maximum heart rate for 30 minutes a day, 3 times per week, for 6 months.

Sponsors & Collaborators

  • Rush University Medical Center

    collaborator OTHER

  • Shirley Ryan AbilityLab

    collaborator OTHER

  • Northwestern University

    lead OTHER

Principal Investigators

  • Daniel Corcos, PhD · Northwestern University

  • Jennifer Goldman, MD · Rush University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2018-11-05
Completion
2019-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03542474 on ClinicalTrials.gov